Literature DB >> 24449161

Multilevel ordinal factor analysis of the positive and negative syndrome scale (PANSS).

Jan Stochl1, Peter B Jones, James Plaistow, Ulrich Reininghaus, Stefan Priebe, Jesus Perez, Tim J Croudace.   

Abstract

Clinical assessments of the presence and severity of psychopathology are often collected by health care professionals in mental health services or clinical researchers trained to use semi-structured interviews. Clustering by interviewer or rater needs to be considered when performing psychometric analyses such as factor analysis or item response modelling as non-independence of observations arises in these situations. We apply more suitable multilevel methods to analyse ordinally scored Positive and Negative Syndrome Scale (PANSS) items. Our aim is to highlight the differences in results that occur when the data are analysed using a hierarchically sensitive approach rather than using a traditional (aggregated) analysis. Our sample (n = 507) consisted of patients diagnosed with schizophrenia who participated in a multi-centre randomized control clinical trial, the DIALOG study. Analyses reported and compared include an exploratory factor analysis as well as several recently published multifactor models re-estimated within a confirmatory analysis framework. Our results show that the fit of the model and the parsimony of the exploratory factor analysis (EFA) models indicated by the number of factors necessary to explain the inter-correlation among PANSS items improved significantly when data clustering is taken into account through multilevel analysis. Our modeling results support the pentagonal PANSS model first proposed by White et al. (1997).
Copyright © 2014 John Wiley & Sons, Ltd. Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  psychometrics; psychoses; scale validation

Mesh:

Year:  2014        PMID: 24449161      PMCID: PMC6878411          DOI: 10.1002/mpr.1429

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  35 in total

1.  Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the positive and negative syndrome scale.

Authors:  R Mass; T Schoemig; K Hitschfeld; E Wall; C Haasen
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

2.  Factor structure and external validity of the PANSS revisited.

Authors:  Edwin J C G Van den Oord; Dan Rujescu; Jaime R Robles; Ina Giegling; Claire Birrell; József Bukszár; Lenn Murrelle; Hans-Jürgen Möller; Lefkos Middleton; Pierandrea Muglia
Journal:  Schizophr Res       Date:  2005-10-17       Impact factor: 4.939

3.  A confirmatory factor analytic evaluation of the pentagonal PANSS model.

Authors:  Paul B Fitzgerald; Anthony R de Castella; Karren Brewer; Kate Filia; Jenny Collins; P Davey; T Rolfe; J Kulkarni
Journal:  Schizophr Res       Date:  2003-05-01       Impact factor: 4.939

4.  The reliability and validity of general psychotic rating scales with people with mild and moderate intellectual disabilities: an empirical investigation.

Authors:  C Hatton; G Haddock; J L Taylor; J Coldwell; R Crossley; N Peckham
Journal:  J Intellect Disabil Res       Date:  2005-07

5.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

6.  Validity and reliability of the French-language version of the Positive and Negative Syndrome Scale (PANSS).

Authors:  C Lançon; G Reine; P M Llorca; P Auquier
Journal:  Acta Psychiatr Scand       Date:  1999-09       Impact factor: 6.392

7.  Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS).

Authors:  C Lançon; P Auquier; G Nayt; G Reine
Journal:  Schizophr Res       Date:  2000-05-05       Impact factor: 4.939

8.  The five symptom dimensions and depression in schizophrenia.

Authors:  Kwang-Hyuk Lee; Anthony W Harris; Carmel M Loughland; Leanne M Williams
Journal:  Psychopathology       Date:  2003 Sep-Oct       Impact factor: 1.944

9.  Pyramidical model of schizophrenia.

Authors:  S R Kay; S Sevy
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

10.  Multilevel investigation of variation in HoNOS ratings by mental health professionals: a naturalistic study of consecutive referrals.

Authors:  R Ecob; T J Croudace; I R White; J E Evans; G L Harrison; D Sharp; P B Jones
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

View more
  4 in total

1.  Effects of sample size and distributional assumptions on competing models of the factor structure of the PANSS and BPRS.

Authors:  Stephen J Tueller; Kiersten L Johnson; Kevin J Grimm; Sarah L Desmarais; Brian G Sellers; Richard A Van Dorn
Journal:  Int J Methods Psychiatr Res       Date:  2016-12-02       Impact factor: 4.035

2.  Dynamic interplay between life events and course of psychotic disorders: 10-year longitudinal study following first admission.

Authors:  Kayla R Donaldson; Katherine G Jonas; Yuan Tian; Emmett M Larsen; Daniel N Klein; Aprajita Mohanty; Evelyn J Bromet; Roman Kotov
Journal:  Psychol Med       Date:  2020-11-04       Impact factor: 10.592

3.  Effects of ignoring clustered data structure in confirmatory factor analysis of ordered polytomous items: a simulation study based on PANSS.

Authors:  Jan Stochl; Peter B Jones; Jesus Perez; Golam M Khandaker; Jan R Böhnke; Tim J Croudace
Journal:  Int J Methods Psychiatr Res       Date:  2015-06-20       Impact factor: 4.035

4.  Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study.

Authors:  Konstantinos N Fountoulakis; Elena Dragioti; Antonis T Theofilidis; Tobias Wikilund; Xenofon Atmatzidis; Ioannis Nimatoudis; Erik Thys; Martien Wampers; Luchezar Hranov; Trayana Hristova; Daniil Aptalidis; Roumen Milev; Felicia Iftene; Filip Spaniel; Pavel Knytl; Petra Furstova; Tiina From; Henry Karlsson; Maija Walta; Raimo K R Salokangas; Jean-Michel Azorin; Justine Bouniard; Julie Montant; Georg Juckel; Ida S Haussleiter; Athanasios Douzenis; Ioannis Michopoulos; Panagiotis Ferentinos; Nikolaos Smyrnis; Leonidas Mantonakis; Zsófia Nemes; Xenia Gonda; Dora Vajda; Anita Juhasz; Amresh Shrivastava; John Waddington; Maurizio Pompili; Anna Comparelli; Valentina Corigliano; Elmars Rancans; Alvydas Navickas; Jan Hilbig; Laurynas Bukelskis; Lidija Injac Stevovic; Sanja Vodopic; Oluyomi Esan; Oluremi Oladele; Christopher Osunbote; Janusz Κ Rybakowski; Pawel Wojciak; Klaudia Domowicz; Maria Luisa Figueira; Ludgero Linhares; Joana Crawford; Anca-Livia Panfil; Daria Smirnova; Olga Izmailova; Dusica Lecic-Tosevski; Henk Temmingh; Fleur Howells; Julio Bobes; Maria Paz Garcia-Portilla; Leticia García-Alvarez; Gamze Erzin; Hasan Karadağ; Avinash De Sousa; Anuja Bendre; Cyril Hoschl; Cristina Bredicean; Ion Papava; Olivera Vukovic; Bojana Pejuskovic; Vincent Russell; Loukas Athanasiadis; Anastasia Konsta; Dan Stein; Michael Berk; Olivia Dean; Rajiv Tandon; Siegfried Kasper; Marc De Hert
Journal:  Int J Neuropsychopharmacol       Date:  2019-11-01       Impact factor: 5.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.